Prime Risk Factors to Act as Biomarkers for the Diagnosis of Myocardial Infarction

Manish Kr Verma, Pradeep Kumar, Anand Narayan Singh, Preeti Sharma, Suman Kumar, Desh Deepak Singh, Poonam Verma, Rachna Sharma
2021 Journal of Pharmaceutical Research International  
Aims: This study was done to find out retrospective case-control with respect to myocardial infarction diagnosis on the basis of biochemical markers and lipid profile characteristics. Design and Setting: This study was conducted at the Department of Biochemistry and sample collection at LPS Institute of Cardiology & Cardiac Surgery Department, Kanpur. Methods: The total number of subjects participated in this study (n=178), of either sex (with age>65years) were included in this study from the
more » ... is study from the case collected from Outpatient Department (OPD) and Indoor Patient Department (IPD) and control from patients attendant, which consisted of two subject groups: The group I: myocardial infarction (cases) n= 89 and Group II: Healthy Subjects (controls) n= 89. Laboratory methodology was performed to determine the prime important risk factors such as body mass index (BMI), blood pressure and lipid profile characteristics associated with myocardial infarction. Risk factors were analyzed by Chi-square and Pearson correlation, receiver operating characteristic (ROC) curve method considered significant when the critical, P <0.01level was set up, for a 95% confidence interval. Results: Total number of (n=178) participants (males=65; mean age of 65 years, females=24, mean age of 58 years) at 95% CI were considered in this study, out of these, 89 individuals were expected to have risk of myocardial infarction (especially observed in case groups), and remaining 89 individuals were considered as control groups, all were included as, study subjects. Conclusion: The current study concludes the importance of myocardial infarction in presence of prognostic inflammatory markers: higher IL-6 and plasma fibrinogen level, instead of high-sensitivity C-reactive protein, incase and control groups.
doi:10.9734/jpri/2021/v33i24b31435 fatcat:jnxgei5vvvgqhd7ffv745g2syq